SCHEMBL4637340

SCHEMBL4637340

Nc1cc(Cl)cc(Cl)c1S(=O)(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
CYP3A4 P08684 5/20 0.42
TSHR P16473 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 4/20 0.42
RECQL P46063 2/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 2/20 0.42
THRB P10828 1/20 0.42
CASP1 P29466 1/20 0.42
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 3/20 0.39
TP53 P04637 1/20 0.37
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
NR3C1 P04150 4/20 0.36
NR3C2 P08235 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132764 0.84 ALDH1A1 (0.43) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL645734 0.82 CYP2C9 (0.42) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL9297596 0.82 NT5E (0.46) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL544443 0.81 CA1 (0.41) CYP3A4TSHRALDH1A1HSD17B10RECQL
SCHEMBL6553103 0.81 CA1 (0.47) CYP3A4TSHRCA1CA2CA9
SCHEMBL10599464 0.80 ALDH1A1 (0.41) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL11590928 0.80 CYP3A4 (0.41) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL7904984 0.77 TSHR (0.48) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL342035 0.76 ALDH1A1 (0.52) CYP2C9CYP3A4TSHRALDH1A1HSD17B10
SCHEMBL28746009 0.75 CYP2C9 (0.38) CYP2C9CYP3A4TSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934187-A1 NOVEL BENZIMIDAZOLE AND BENZOTHIAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS Aventis Pharma S.A. (FR) 2008-06-25 EP disclosed
WO-2007036630-A1 NOVEL BENZIMIDAZOLE AND BENZOTHIAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, USE THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS AVENTIS PHARMA S.A. (FR) 2007-04-05 WO disclosed